{
    "paper_id": "PMC7171712",
    "metadata": {
        "title": "Kaempferol Derivatives as Antiviral Drugs against the 3a Channel\nProtein of Coronavirus",
        "authors": [
            {
                "first": "Silvia",
                "middle": [],
                "last": "Schwarz",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Daniel",
                "middle": [],
                "last": "Sauter",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Kai",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Ronghua",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Bing",
                "middle": [],
                "last": "Sun",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Anastasia",
                "middle": [],
                "last": "Karioti",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Anna",
                "middle": [
                    "Rita"
                ],
                "last": "Bilia",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Thomas",
                "middle": [],
                "last": "Efferth",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Wolfgang",
                "middle": [],
                "last": "Schwarz",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Various herbal antiviral drugs have been developed that interfere with the viral life\ncycle 1. During the first appearance of SARS about\n50 % of the patients in mainland China were treated successfully with Chinese herbal\nmedicine in addition to Western medicine 2, 3.",
            "cite_spans": [
                {
                    "start": 92,
                    "end": 93,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 263,
                    "end": 264,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 266,
                    "end": 267,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Several viruses encode for ion-selective channels that become incorporated into the\nmembrane of the infected cell 4, 5, 6, 7. Activation of such channels seems to be involved in\nthe process of virus production and release 8, 9, 10, 11, 12. Hence,\ninhibition of the ion channel activation will counteract virus production; this may\nallow the infected body to build up or strengthen its own immune system. The viral\nion channel will, therefore, be a potential candidate for developing new antiviral\ndrugs. The ORF 3a of SARS CoV encodes for an ion-permeable channel. We could\npreviously demonstrate that micromolar concentrations of the anthraquinone emodin\ncan inhibit the 3a channel activity with an IC50 value of only 20 \u00b5M and\nalso inhibit coronavirus release with a similar sensitivity from infected cells\n13. This indicates that the viral ion channel is\nan interesting target for antiviral drugs.",
            "cite_spans": [
                {
                    "start": 114,
                    "end": 115,
                    "mention": "4",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 117,
                    "end": 118,
                    "mention": "5",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 120,
                    "end": 121,
                    "mention": "6",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 123,
                    "end": 124,
                    "mention": "7",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 222,
                    "end": 223,
                    "mention": "8",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 225,
                    "end": 226,
                    "mention": "9",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 228,
                    "end": 230,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 232,
                    "end": 234,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 236,
                    "end": 238,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 809,
                    "end": 811,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Emodine as well as various flavonoids (Fig. 1) are\nwell known to act as anticancer drugs 14, 15, but they were also discussed as antiviral drugs\n16. The flavonol kaempferol and its glycosides\nhave been reported previously to have high antiviral activity 1, but effects on the intracellular events were favoured as an\nexplanation 17, 18.\nHere we investigated whether the flavonol kaempferol and kaempferol glycosides can\nblock the 3a channel. In addition, we tested a number of other flavonoids (Fig. 1). This manuscript extends preliminary data 1 to investigate the role of this class of compounds in\nmore detail.",
            "cite_spans": [
                {
                    "start": 89,
                    "end": 91,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 93,
                    "end": 95,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 145,
                    "end": 147,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 254,
                    "end": 255,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 329,
                    "end": 331,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 333,
                    "end": 335,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 545,
                    "end": 546,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 39,
                    "end": 45,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 495,
                    "end": 501,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "The flavonoids listed in Table 1 are well known for\ntheir anticancer activity, but also various antiviral effects have been reported\n18, 19, 20. Here we investigated these drugs with respect to\ntheir efficacy to inhibit Ba2+-sensitive current. Fig. 2 a shows that 20 \u00b5M kaempferol reduced endogenous\nBa2+-sensitive current. At \u2212 100 mV the current was inhibited to\n0.77 \u00b1 0.08 (p < 0.01) of the control current in the absence of the drug. The\ndegree of inhibition was independent of voltage.",
            "cite_spans": [
                {
                    "start": 133,
                    "end": 135,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 137,
                    "end": 139,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 141,
                    "end": 143,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Results and Discussion",
            "ref_spans": [
                {
                    "start": 244,
                    "end": 252,
                    "mention": "Fig. 2 a",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 25,
                    "end": 32,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "In oocytes with expressed 3a protein, Ba2+-sensitive current was larger by\na factor of about 3 to 5 than in control oocytes (compare Fig. 2 a and b). Kaempferol also affected\nthis additional 3a-mediated current component (Fig. 2 b). After subtraction of the endogenous contribution (Fig. 2 c), the current at \u2212 100 mV was reduced to\n0.82 \u00b1 0.10 of the current component in the absence of drug; this indicated that the\nendogenous and the 3a-mediated components exhibited similar sensitivity to\nkaempferol. This is in contrast to emodin which selectively inhibited the\n3a-mediated current and at 20 \u00b5M already produced more than 50 % block (see 13). The poor solubility of kaempferol in water did not\nallow testing a higher concentration for evaluation of an IC50 value. We\ntherefore did not further follow up the effect of kaempferol, but rather screened\nfor the effect of various other flavonoids. In particular, the glycosides (Table 1) are water-soluble and in addition exhibit\nhigher bioavailability 21.",
            "cite_spans": [
                {
                    "start": 643,
                    "end": 645,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1003,
                    "end": 1005,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Results and Discussion",
            "ref_spans": [
                {
                    "start": 133,
                    "end": 141,
                    "mention": "Fig. 2 a",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 146,
                    "end": 147,
                    "mention": "b",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 222,
                    "end": 230,
                    "mention": "Fig. 2 b",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 283,
                    "end": 291,
                    "mention": "Fig. 2 c",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 929,
                    "end": 936,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "In contrast to kaempferol, the tested kaempferol glycosides hardly affected\nBa2+-sensitive endogenous current (for juglanin see, e.g., Fig. 3 a). In oocytes with an expressed 3a protein,\nstronger effects could be detected than with kaempferol (compare Table 1). Juglanin seemed to be the most potent\nkaempferol glycoside that gave complete inhibition at 20 \u00b5M; even 10 \u00b5M produced\nnearly complete inhibition. Therefore, we focussed on this drug for a more detailed\nanalysis. Fig. 3 b illustrates the effect of two\nconcentrations on the current-voltage dependencies of Ba2+-sensitive\ncurrent in 3a protein-expressing oocytes. Already 2.5 \u00b5M exhibited a significant\ninhibition. The dependence of the 3a-mediated current component on juglanin\nconcentration is shown in Fig. 3 c. The dashed line\nis a fit to the data of",
            "cite_spans": [],
            "section": "Results and Discussion",
            "ref_spans": [
                {
                    "start": 135,
                    "end": 143,
                    "mention": "Fig. 3 a",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 475,
                    "end": 483,
                    "mention": "Fig. 3 b",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 766,
                    "end": 774,
                    "mention": "Fig. 3 c",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 252,
                    "end": 259,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "At a concentration of about 2.3 \u00b5M juglanin, 50 % inhibition (IC50) was\nobtained. Hence juglanin is about one order of magnitude more potent to block\n3a-protein channel than emodine 13. With an even\nhigher IC50 value of 200 \u00b5M, emodine was shown to inhibit interaction\nbetween virus and host cell, which was considered to be a potent mechanism in herbal\ntreatment of SARS 22. The higher sensitivity of the\n3a channel makes this protein an even more interesting target for drug\ndevelopment.",
            "cite_spans": [
                {
                    "start": 182,
                    "end": 184,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 372,
                    "end": 374,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Two other tested kaempferol glycosides, tiliroside and afzelin, were less potent than\njuglanin but were nevertheless as effective as emodine. Tiliroside at 20 \u00b5M produced\na block to 0.48 \u00b1 0.09 (Table 1 and Fig. 3 d); at the same concentration, juglanin\ncompletely blocked the 3a-mediated current (Table 1\nand Fig. 3 b and d). A\nsimilar degree of inhibition as with 20 \u00b5M kaempferol was obtained with only 10 \u00b5M\nof afzelin (inhibition to 0.83 \u00b1 0.01) compared to the current in the absence of\ndrug (Table 1 and Fig. 3 d).",
            "cite_spans": [],
            "section": "Results and Discussion",
            "ref_spans": [
                {
                    "start": 207,
                    "end": 215,
                    "mention": "Fig. 3 d",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 310,
                    "end": 318,
                    "mention": "Fig. 3 b",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 323,
                    "end": 324,
                    "mention": "d",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 511,
                    "end": 519,
                    "mention": "Fig. 3 d",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 195,
                    "end": 202,
                    "mention": "Table 1",
                    "ref_id": null
                },
                {
                    "start": 298,
                    "end": 305,
                    "mention": "Table 1",
                    "ref_id": null
                },
                {
                    "start": 499,
                    "end": 506,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "In a series of experiments, we also tested the acylated kaempferol derivatives\nkaempferol-3-O-(2,6-di-p-coumaroyl)-glucopyranoside and\nkaempferol-3-O-(3,4-diacetyl-2,6-di-p-coumaroyl)-glucoside, which all had\nan additional p-coumaroyl group (see Fig. 1).\nAt 20 \u00b5M, both derivatives showed no effect on Ba2+-sensitive current.\nEven at concentrations up to 40 \u00b5M (Table 1), no\nsignificant inhibition could be detected. On the other hand, in a few orientating\nexperiments, we found that the kaempferol triglycoside\nkaempferol-3-O-\u03b1-rhamnopyranosyl(1 \u2192 2)[\u03b1-rhamnopyranosyl(1 \u2192 6)]-\u03b2-glucopyranoside\nexhibited about 30 % inhibition at 20 \u00b5M (Table 1);\nthis was similar to the effect of afzelin which was also applied at 20 \u00b5M in two of\nthese experiments. Interestingly, both drugs are characterized by rhamnose residues\n(see Fig. 1).",
            "cite_spans": [],
            "section": "Results and Discussion",
            "ref_spans": [
                {
                    "start": 246,
                    "end": 252,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 821,
                    "end": 827,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 362,
                    "end": 369,
                    "mention": "Table 1",
                    "ref_id": null
                },
                {
                    "start": 638,
                    "end": 645,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "As another flavonol, we tested the effect of quercetin, which was reported to also\nact as an effective drug against virus infections including SARS CoV 23. We found that the 3a-mediated current was not\nsignificantly affected by 10 \u00b5M quercetin (see Table\n1); concentrations even up to 50 \u00b5M hardly affected the 3a-mediated\ncurrent. Also the quercetin derivative with an arabinofuranoside, avicularin (not\nshown), was without any effect.",
            "cite_spans": [
                {
                    "start": 152,
                    "end": 154,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                }
            ],
            "section": "Results and Discussion",
            "ref_spans": [
                {
                    "start": 249,
                    "end": 256,
                    "mention": "Table\n1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "The flavanone naringenin and the isoflavone genistein are also known for their\nantiviral potency (see, e.g., 24, 25, 26), but neither\nnaringenin nor genistein exhibited any significant modulation of the 3a-mediated\ncurrent (see Table 1).",
            "cite_spans": [
                {
                    "start": 109,
                    "end": 111,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 113,
                    "end": 115,
                    "mention": "25",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 117,
                    "end": 119,
                    "mention": "26",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "Results and Discussion",
            "ref_spans": [
                {
                    "start": 228,
                    "end": 235,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "Though the flavonols quercetin and avicularin, the flavanone naringenin, and the\nisoflavone genistein do not affect the activity of the 3a protein, the flavonol\nkaempferol exhibits a clear inhibition of the 3a-mediated current; the kaempferol\nglycosides are even more potent inhibitors thus suggesting an importance of sugar\nresidues. The most potent drug was the kaempferol glycoside juglanin with an\narabinose residue. Interestingly, the kaempferol glycoside afzelin and the\ntriglycoside with rhamnose residues seem also to be quite effective. In addition to\nthe higher effectivity of the flavonoid glycosides to inhibit the 3a protein ion\nchannel, they show higher solubility in water with higher bioactivity 19, 21.",
            "cite_spans": [
                {
                    "start": 712,
                    "end": 714,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 716,
                    "end": 718,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Though flavonoid glycosides may be absorbed in the small intestine, biodegradation\nwill limit their therapeutical application, and levels in plasma are probably below\n1 \u00b5M 21. An important task for developing new\nantiviral drugs will therefore have to focus on improving bioactivity 27; several strategies have been tackled for increasing\nbioavailability including drug delivery and metabolic stability (compare 19, 21, 27, 28).",
            "cite_spans": [
                {
                    "start": 172,
                    "end": 174,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 283,
                    "end": 285,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 412,
                    "end": 414,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 416,
                    "end": 418,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 420,
                    "end": 422,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 424,
                    "end": 426,
                    "mention": "28",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Activity of the 3a protein results in ion channel gating which allows small cations\nto cross the membrane. Although the channel shows selectivity for K+,\nalso Na+ can penetrate with slightly lower permeability 11. As a consequence, activity of channel openings will\nlead to membrane depolarization, and activation of L-type Ca2+ channels\n29 to an elevation of intracellular\nCa2+\n30. This could account for the 3a-protein-dependent\nrelease of CoV from infected cells via exocytosis. Indeed, inhibition of 3a channel\nactivity blocks virus release; this could be demonstrated by suppression of 3a\nexpression as well as pharmacological inhibition of the 3a channel 11, 13. This reduction\nin virus production offers the body the chance to adjust its immune system to\ncounteract the viral attack. Inhibition of ion channels encoded by other viruses\ncould also be demonstrated to inhibit the respective virus production 31, 32, 33.",
            "cite_spans": [
                {
                    "start": 210,
                    "end": 212,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 338,
                    "end": 340,
                    "mention": "29",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 379,
                    "end": 381,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 661,
                    "end": 663,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 665,
                    "end": 667,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 913,
                    "end": 915,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 917,
                    "end": 919,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 921,
                    "end": 923,
                    "mention": "33",
                    "ref_id": "BIBREF26"
                }
            ],
            "section": "Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "As a conclusion, we suggest that emodin and kaempferol could form the basis for the\ndevelopment of new antiviral drugs with higher bioavailability. In particular, the\nglycosides of kaempferol seem to be highly potent candidates for development as\nanti-coronaviral agents. The fact that these drugs not only block the 3a channel,\nthus counteracting virus production, but that they also interfere with other steps\nof the viral life cycle 20 emphasises the importance\nof multi-target drugs.",
            "cite_spans": [
                {
                    "start": 436,
                    "end": 438,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "To investigate effects of kaempferol and its derivatives on the 3a protein of\nSARS-CoV, we used the Xenopus oocyte for heterologous expression and\napplied voltage-clamp techniques (for details see 11, 13). Females of the clawed toad\nXenopus laevis (Maosheng Bio-Technology Com.) were anaesthetized with\ntricane (1 g/L H2O, MS222; Sandoz) or in ice water. Parts of the\novary were removed and treated with 0.3 units/mL Liberase (Roche) or with\n1 mg/mL Collagenase (Sigma) for 3 to 4 h to remove enveloping tissue and to\nobtain isolated oocytes. The entire procedure follows standard protocols\nincluding care of laboratory animals that have been established according to\nGerman Animal Protection Law. For expression of 3a protein, oocytes of stage V\nor VI 34 were selected and injected with 20 or\n30 ng cRNA for 3a protein (for details see 11)\n(at 1 ng/nL) two to three days before the experiments; uninjected oocytes served\nas controls. The cells were stored for 2 days at 19 \u00b0C in oocyte Ringer\u02bcs-like\nsolution (G-ORi, see solutions). Experiments were performed at room temperature\n(24\u201326 \u00b0C).",
            "cite_spans": [
                {
                    "start": 197,
                    "end": 199,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 201,
                    "end": 203,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 753,
                    "end": 755,
                    "mention": "34",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 837,
                    "end": 839,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Expression of 3a protein in Xenopus oocytes\n ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "Standard ORi solution contained: 90 mM NaCl, 2 mM KCl, 2 mM CaCl2, and\n5 mM Hepes (adjusted to pH 7.4 with Tris). For cell incubation, the ORi was\nsupplemented with 70 \u00b5g/L gentamycin (G-ORi).",
            "cite_spans": [],
            "section": "Solutions ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "Since the 3a protein channel showed high permeability to K+\n11, the test solution without Ba2+\n(S1) contained: 100 mM KCl, 2 mM MgCl2, and 5 mM Hepes (pH 7.4);\nbecause the Xenopus oocytes express endogenous Ca2+-activated\nK+ and Cl\u2212 channels, Ca2+ was omitted from\nthe bath solutions (but replaced by Mg2+) to reduce these background\ncurrents. Test solution S2 contained 10 mM BaCl2 in addition. The\nchange in osmolarity due to addition of BaCl2 did not affect the\nmembrane currents. The difference between the current measured in S1 and S2 was\nconsidered as the Ba2+-sensitive current component. Both solutions,\nS1 and S2, contained some DMSO (see below).",
            "cite_spans": [
                {
                    "start": 60,
                    "end": 62,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Solutions ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "All stock solutions of drugs were made up in DMSO. Kaempferol was purchased from\nSigma-Aldrich; two probes of the kaempferol glycosides (juglanin,\nkaempferol-3-O-\u03b1-L-arabinofuranoside, and afzelin,\nkaempferol-3-O-\u03b1-L-rhamnoside) were kindly provided by Prof. X. Hao\nand Dr. Y. Wang, Kunming, China, or bought from BioBioPHa.",
            "cite_spans": [],
            "section": "Solutions ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "Kaempferol acylated glucosides were previously isolated from polar extracts from\nthe leaves of the plant Quercus ilex L. 35; the kaempferol triglycoside was an isolate from Viola odorata\nL. 36. Isolation was carried out mainly by column\nchromatography on Sephadex LH-20 and silica gel. The structure of the compounds\nwas established by NMR experiments. The purity was checked by NMR and\nhigh-performance liquid chromatography with diode array detector and was over\n95 %. Quercetin and naringenin were purchased from Sigma-Aldrich, and genistein\nfrom Sinopharm Chemical Reagent Co., Ltd. The purities of all drugs are listed\nin Table 1.",
            "cite_spans": [
                {
                    "start": 121,
                    "end": 123,
                    "mention": "35",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 190,
                    "end": 192,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Solutions ::: Materials and Methods",
            "ref_spans": [
                {
                    "start": 627,
                    "end": 634,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "We applied conventional two-electrode voltage clamp using Turbo TEC-03 with\nCellWorks software (NPI Electronic) to measure the current mediated by SARS-3a\nprotein. This method allowed directly monitoring modulations of the ion channel\nfunction under various conditions including inhibition by drugs. Previously, we\nhad successfully applied this method to show that emodin (purity > 95 %)\ninhibits ion flow through the 3a protein ion channel 13. To determine steady-state current\u2013voltage dependencies (IV\ncurves), membrane currents were averaged during the last 20 ms of 200 ms,\nrectangular voltage pulses from \u2212 150 to + 30 mV in 10-mV increments; the pulses\nwere applied from a holding potential of \u2212 60 mV. To avoid changes at the bath\nelectrodes due to changes in Cl\u2212 activity, the electrodes were\nuncoupled from the bath via ORi-filled channels.",
            "cite_spans": [
                {
                    "start": 441,
                    "end": 443,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Voltage\u2013clamp experiments ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "Current mediated by the 3a protein can be blocked by Ba2+\n11. Therefore, we determined\nBa2+-sensitive current as the difference of steady-state current in\nthe presence and absence of 10 mM BaCl2 (see Solutions). Since\noocytes which did not express 3a protein also exhibited some\nBa2+-sensitive current contribution, this endogenous component was\ndetermined in uninjected control cells and used for subtraction from total\nBa2+-sensitive current of the injected oocytes from the same\nbatch. The difference was considered to represent 3a-mediated current.",
            "cite_spans": [
                {
                    "start": 58,
                    "end": 60,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Voltage\u2013clamp experiments ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "To correct for possible drift with time, Ba2+-sensitive current was\ncalculated according to:",
            "cite_spans": [],
            "section": "Voltage\u2013clamp experiments ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "or",
            "cite_spans": [],
            "section": "Voltage\u2013clamp experiments ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "\nIS1 and IS2 stand for current measurements in the absence and\npresence of the Ba2+, respectively, the subscripts before\nand after refer to measurements before and after the measurement with\nthe respective other solution. For a typical experiment, either of the following\nsequences of solutions was used for perfusing the chamber with the oocyte:",
            "cite_spans": [],
            "section": "Voltage\u2013clamp experiments ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "S1 \u2192 S2 \u2192 S1 \u2192 S1+ \u2192 S2+ \u2192 S1+ \u2192 S1 \u2192 S2 \u2192 S1",
            "cite_spans": [],
            "section": "Voltage\u2013clamp experiments ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "S2 \u2192 S1 \u2192 S2 \u2192 S2+ \u2192 S1+ \u2192 S2+ \u2192 S2 \u2192 S1 \u2192 S2.",
            "cite_spans": [],
            "section": "Voltage\u2013clamp experiments ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "The + sign indicates solutions with the respective drug.",
            "cite_spans": [],
            "section": "Voltage\u2013clamp experiments ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "We gratefully acknowledge the technical assistance from Huiming Du during the various\nsteps of this project. SS, DS, and WS thank Prof. Gu Quanbao for helpful\ndiscussions. The work was supported by the National Basic Research Program of China\n(973 Program, 2012CB518502). We also gratefully acknowledge the support from Green\nValley Holding Co, Shanghai.",
            "cite_spans": [],
            "section": "Acknowledgements",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Fig.\u20091: \n Structure of the flavonoids tested with respect to their effects on\nthe 3a-mediated current. The flavonol kaempferol (1) and the kaempferol\nglycosides afzelin (2), juglanine (3), and tiliroside (4),\nas well as two tiliroside derivatives (5\u20136), the kaempferol\ntriglycoside (7), the flavonol quercetin (8), the flavanone\nnaringenin (9), and the isoflavone genistein (10). Rha stands for\nrhamnose and Araf for arabinofuranose. For their respective effects, compare\nTable 1.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Fig.\u20092: \n Effect of kaempferol on current-voltage (IV) curves of\nBa2+-sensitive current. Open squares describe the current-voltage\ndependencies in the absence and filled squares in the presence of 20 \u00b5M\nkaempferol. a Endogenous currents, b currents of cells with\nheterologously expressed 3a protein, and c the 3a-protein-mediated\ncurrent component (endogenous current subtracted). Data represent averages of\nn = 4 to 7 experiments \u00b1 SEM.",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Fig.\u20093: \n Effect of kaempferol glycosides on Ba2+-sensitive and\n3a-mediated current. Results in the absence of drug are given by open squares\nand in the presence of drug by filled symbols. a Effect of 10 \u00b5M juglanin\non current-voltage dependencies of Ba2+-sensitve current in control\noocytes without a 3a protein. b Effect of 2.5 (filled squares) and 10 \u00b5M\n(filled circles) juglanin on 3a-mediated current that was determined as the\ndifference of Ba2+-sensitive current in a 3a-expressing cells. Data\npoints represent averages from 4\u20137 experiments \u00b1 SEM. c Inhibition of a\n3-mediated current at \u2212 100 mV by juglanin. The data points represent averages\n\u00b1 SEM of 5\u201317 measurements. The dashed line is an approximation of equ. 1 to the\ndata points with n = 1.2 and K1/2 = 2.3 \u00b5M. d Effect of 20 \u00b5M\ntiliroside (squares) and 10 \u00b5M afzelin (circles) on voltage dependence of a\nBa2+-sensitive current in 3a-expressing cell. Data points\nrepresent averages from 4\u20137 experiments \u00b1 SEM.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Coronaviral ion channels as target for Chinese herbal medicine",
            "authors": [],
            "year": 2012,
            "venue": "Forum Immunopathol Dis Ther",
            "volume": "3",
            "issn": "",
            "pages": "1-13",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Structure-function correlates of Vpu, a membrane protein of HIV-1",
            "authors": [],
            "year": 2003,
            "venue": "FEBS Lett",
            "volume": "552",
            "issn": "",
            "pages": "47-53",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion\nchannel and modulates virus release",
            "authors": [],
            "year": 2006,
            "venue": "Proc Natl Acad Sci USA",
            "volume": "103",
            "issn": "",
            "pages": "12540-12545",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Coronaviral ion channels as target for Chinese herbal medicine",
            "authors": [],
            "year": 2012,
            "venue": "Forum Immunopathol Dis Ther",
            "volume": "3",
            "issn": "",
            "pages": "1-13",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Emodin inhibits current through SARS-associated coronavirus 3a protein",
            "authors": [],
            "year": 2011,
            "venue": "Antivir Res",
            "volume": "90",
            "issn": "",
            "pages": "64-69",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Anti-cancer natural products isolated from Chinese medicinal herbs",
            "authors": [],
            "year": 2011,
            "venue": "Chin Med",
            "volume": "6",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Anthracycline and anthraquinone anticancer agents: Current status and recent\ndevelopments",
            "authors": [],
            "year": 1993,
            "venue": "Pharmacol Ther",
            "volume": "60",
            "issn": "",
            "pages": "185-214",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Antiviral activity of phytochemicals: A comprehensive review",
            "authors": [],
            "year": 2008,
            "venue": "Minirev Med Chem",
            "volume": "8",
            "issn": "",
            "pages": "1106-1133",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Antiherpetic activities of flavonoids against herpes simplex virus type 1\n(HSV-1) and type 2 (SV-2) in vitro",
            "authors": [],
            "year": 2005,
            "venue": "Arch Pharm Res",
            "volume": "28",
            "issn": "",
            "pages": "1293-1301",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Evaluation of the antiviral activity of kaempferol and its glycosides against\nhuman cytomegalovirus",
            "authors": [],
            "year": 2000,
            "venue": "Planta Med",
            "volume": "66",
            "issn": "",
            "pages": "377-379",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Flavonoids: a review of probable mechanisms of action and potential\napplications",
            "authors": [],
            "year": 2001,
            "venue": "Am J Clin Nutr",
            "volume": "74",
            "issn": "",
            "pages": "418-425",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Effect of integrated traditional Chinese and Western medicine on SARS: A review\nof clinical evidence",
            "authors": [],
            "year": 2004,
            "venue": "World J Gastroenterol",
            "volume": "10",
            "issn": "",
            "pages": "3500-3505",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Antiviral effect of flavonoids on human viruses",
            "authors": [],
            "year": 1985,
            "venue": "J Med Virol",
            "volume": "15",
            "issn": "",
            "pages": "71-79",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Absorption, bioavailability, and metabolism of flavonoids",
            "authors": [],
            "year": 2004,
            "venue": "Pharm Biol",
            "volume": "42",
            "issn": "",
            "pages": "74-83",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Emodin blocks the SARS coronavirus spike protein and angiotensin-converting\nenzyme 2 interaction",
            "authors": [],
            "year": 2007,
            "venue": "Antivir Res",
            "volume": "74",
            "issn": "",
            "pages": "92-101",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Binding interaction of quercetin-3-\u03b2-galactoside and its synthetic\nderivatives with SARS-CoV 3\u2009CLpro: Structure activity relationship\nstudies reveal salient pharmacophore features",
            "authors": [],
            "year": 2006,
            "venue": "Bioorg Med Chem",
            "volume": "14",
            "issn": "",
            "pages": "8295-8306",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Antiherpetic activities of flavonoids against herpes simplex virus type 1\n(HSV-1) and type 2 (HSV-2) in vitro",
            "authors": [],
            "year": 2005,
            "venue": "Arch Pharm Res",
            "volume": "28",
            "issn": "",
            "pages": "1293-1301",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Structure-activity relationship of flavonoids as influenza virus neuraminidase\ninhibitors and their in vitro anti-viral activities",
            "authors": [],
            "year": 2008,
            "venue": "Bioorg Med Chem",
            "volume": "16",
            "issn": "",
            "pages": "7141-7147",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Human cytomegalovirus-inhibitory flavonoids: Studies on antiviral activity and\nmechanism of action",
            "authors": [],
            "year": 2005,
            "venue": "Antiviral Res",
            "volume": "68",
            "issn": "",
            "pages": "124-134",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Flavonoid bioavailability and attempts for bioavailability enhancement",
            "authors": [],
            "year": 2013,
            "venue": "Nutrients",
            "volume": "5",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Absorption and metabolism of flavonoids",
            "authors": [],
            "year": 2004,
            "venue": "Free Radic Biol Med",
            "volume": "36",
            "issn": "",
            "pages": "829-837",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "SARS accessory proteins ORF3a and 9b and their functional analysis",
            "authors": [],
            "year": 2010,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "167-175",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Chinese herbs combined with Western medicine for severe acute respiratory\nsyndrome (SARS)",
            "authors": [],
            "year": 2006,
            "venue": "Cochrane Database Syst Rev",
            "volume": "",
            "issn": "1",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Viral calciomics: Interplays between Ca2+ and virus",
            "authors": [],
            "year": 2009,
            "venue": "Cell Calcium",
            "volume": "46",
            "issn": "",
            "pages": "1-17",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus\nreplication",
            "authors": [],
            "year": 2006,
            "venue": "Virology",
            "volume": "353",
            "issn": "",
            "pages": "294-306",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "A novel Hepatitis C virus p\u200a7 ion channel inhibitor, BIT225, inhibits bovine\nviral diarrhea virus in vitro and shows synergism with recombinant\ninterferon-\u03b1-2b and nucleoside analogues",
            "authors": [],
            "year": 2010,
            "venue": "Antivir Res",
            "volume": "86",
            "issn": "",
            "pages": "144-153",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "DIDS blocks a chloride-dependent current that is mediated by the 2B protein of\nenterovirus 71",
            "authors": [],
            "year": 2011,
            "venue": "Cell Res",
            "volume": "21",
            "issn": "",
            "pages": "1271-1275",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Oogenesis in \u201cXenopus laevis\u201d (Daudin): I. Stages of oocyte development\nin laboratory maintained animals",
            "authors": [],
            "year": 1972,
            "venue": "J Morphol",
            "volume": "136",
            "issn": "",
            "pages": "153-180",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "Quercus ilex L.: A rich source of polyacylated flavonoid glucosides",
            "authors": [],
            "year": 2010,
            "venue": "Food Chem",
            "volume": "123",
            "issn": "",
            "pages": "131-142",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "Analysis of the constituents and quality control of Viola odorata aqueous\npreparations by HPLC-DAD and HPLC-ESI-MS",
            "authors": [],
            "year": 2011,
            "venue": "Anal Bioanal Chem",
            "volume": "399",
            "issn": "",
            "pages": "1715-1723",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Viral membrane proteins",
            "authors": [],
            "year": 2010,
            "venue": "Eur Biophys J",
            "volume": "39",
            "issn": "",
            "pages": "1041-1042",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Assembly of viral membrane proteins",
            "authors": [],
            "year": 2009,
            "venue": "J Chem Theor Comput",
            "volume": "5",
            "issn": "",
            "pages": "2503-2513",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "Viral proteins function as ion channels",
            "authors": [],
            "year": 2011,
            "venue": "Biochim Biophys Acta",
            "volume": "1808",
            "issn": "",
            "pages": "510-515",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Mechanism of function of viral channel protein and implications for drug\ndevelopment",
            "authors": [],
            "year": 2012,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "259-321",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Ion channels as antivirus targets",
            "authors": [],
            "year": 2010,
            "venue": "Virol Sin",
            "volume": "25",
            "issn": "",
            "pages": "267-280",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Demonstrating the intrinsic ion channel activity of virally encoded\nproteins",
            "authors": [],
            "year": 2003,
            "venue": "FEBS Lett",
            "volume": "552",
            "issn": "",
            "pages": "61-67",
            "other_ids": {
                "DOI": []
            }
        }
    }
}